The Company anticipates filing its NDA for GTx-104 in the second quarter of 2025. Acceptance of the NDA will be subject to the FDA’s review of the complete filing.

Edward J. Borkowski , age 65, is a healthcare executive who currently serves as an independent consultant. From April 2023 to July 2024, Mr. Borkowski was Executive Vice President and Chief Financial ...

DataStrike, a leader in data infrastructure managed services, announced today that President Rob Brown and CEO Buddy Flerl will speak at two prominent technology conferences this April. Flerl and ...

Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured ...